Dr. Tamer Mohamed El-Saady reviewed the journey behind establishing Vitame Group and Vita Middle East Pharma, emphasizing that this success is the culmination of over 25 years of hard work and experience within the pharmaceutical and business management sectors.

He explained that his career began within several Egyptian, regional, and multinational companies across the Middle East and North Africa (MENA) region. In 2009, he relocated to the UAE, an experience that helped expand his international network and build strong strategic partnerships.

El-Saady noted that Vitame Group, founded in 2017, has successfully formed partnerships with more than 13 global companies from France, Spain, Italy, Germany, and Turkey, alongside collaborating with over 11 distributors across the Middle East.

He also revealed that he was granted the Golden Visa by the Dubai government under the investors and entrepreneurs category in January 2024. He regarded this milestone as a reflection of the group’s regional expansion and the trust it has built over recent years.

Furthermore, El-Saady added that the company adopts a strategy rooted in innovation, introducing products for the first time to Egypt and the Middle East. This includes bringing in the latest internationally approved treatments for diabetes, gastroenterology, migraines, and ophthalmology.

He concluded by stressing that true business success relies on patience, perseverance, and continuous effort. He underscored the vital importance of having a clear vision and building a competitive advantage based on quality, innovation, and international cooperation.